Effect of ANKASCIN 568-P Products Regulating Blood Lipid

Clinical trial NCT05737355 · RECRUITING

Trial details

NCT number: NCT05737355
Sponsor: SunWay Biotech Co., LTD.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Hyperlipidemias

Start date: 2023-04-01
Primary completion: 2025-10-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.